RE: GSK subject to Manipulation by London Traders23 Feb 2021 00:32
Fats
“Toff, have to disagree on the £20 plus if the main listing was on the NYSE.”
You’re over analyzing- searching to justify the price plunge. You could apply pedantic analysis to any share including the ones that trade on p/e’s of hundreds or even thousands.
Glaxo is cheap by any metric and I don’t need to waste time convincing its isn’t.
All shares are valued differently. Fundamentals have very little to do with it.
And remember I’m a trader not an investor.
Unlike most on these boards who quote Buffett, it’s all about capitalizing on short term shareprice movements momentum and market psychology.
An investor’s mindset is alien to me.
Sorry fats - don’t take this personal - but you can’t see the wood for the trees, you’re getting too wrapped up in detail. Good traders know it’s all about simplicity.
Like ToffAppleton